These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 30455372)
41. Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells. Behar G; Sibéril S; Groulet A; Chames P; Pugnière M; Boix C; Sautès-Fridman C; Teillaud JL; Baty D Protein Eng Des Sel; 2008 Jan; 21(1):1-10. PubMed ID: 18073223 [TBL] [Abstract][Full Text] [Related]
42. Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking. Xi X; Sun W; Su H; Zhang X; Sun F Mol Immunol; 2020 Dec; 128():165-174. PubMed ID: 33130376 [TBL] [Abstract][Full Text] [Related]
43. Preparation and characterization of novel IgG affinity resin coupling anti-Fc camelid single-domain antibodies. Tu Z; Xu Y; Fu J; Huang Z; Wang Y; Liu B; Tao Y J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():26-31. PubMed ID: 25614967 [TBL] [Abstract][Full Text] [Related]
44. Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies. Zhou Y; Goenaga AL; Harms BD; Zou H; Lou J; Conrad F; Adams GP; Schoeberl B; Nielsen UB; Marks JD Mol Cancer Ther; 2012 Jul; 11(7):1467-76. PubMed ID: 22564724 [TBL] [Abstract][Full Text] [Related]
45. Camelid nanobodies: killing two birds with one stone. Desmyter A; Spinelli S; Roussel A; Cambillau C Curr Opin Struct Biol; 2015 Jun; 32():1-8. PubMed ID: 25614146 [TBL] [Abstract][Full Text] [Related]
46. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing. Miyazaki N; Kiyose N; Akazawa Y; Takashima M; Hagihara Y; Inoue N; Matsuda T; Ogawa R; Inoue S; Ito Y J Biochem; 2015 Sep; 158(3):205-15. PubMed ID: 25888581 [TBL] [Abstract][Full Text] [Related]
47. Llama single domain antibodies as a tool for molecular mimicry. Zarebski LM; Urrutia M; Goldbaum FA J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359 [TBL] [Abstract][Full Text] [Related]
48. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607 [TBL] [Abstract][Full Text] [Related]
49. Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein. Togtema M; Hussack G; Dayer G; Teghtmeyer MR; Raphael S; Tanha J; Zehbe I Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035322 [TBL] [Abstract][Full Text] [Related]
50. A rapid live-cell ELISA for characterizing antibodies against cell surface antigens of Chlamydomonas reinhardtii and its use in isolating algae from natural environments with related cell wall components. Jiang W; Cossey S; Rosenberg JN; Oyler GA; Olson BJ; Weeks DP BMC Plant Biol; 2014 Sep; 14():244. PubMed ID: 25252698 [TBL] [Abstract][Full Text] [Related]
51. Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates. van Lith SA; van Duijnhoven SM; Navis AC; Leenders WP; Dolk E; Wennink JW; van Nostrum CF; van Hest JC Bioconjug Chem; 2017 Feb; 28(2):539-548. PubMed ID: 28045502 [TBL] [Abstract][Full Text] [Related]
53. Llama immunization with full-length VAR2CSA generates cross-reactive and inhibitory single-domain antibodies against the DBL1X domain. Nunes-Silva S; Gangnard S; Vidal M; Vuchelen A; Dechavanne S; Chan S; Pardon E; Steyaert J; Ramboarina S; Chêne A; Gamain B Sci Rep; 2014 Dec; 4():7373. PubMed ID: 25487735 [TBL] [Abstract][Full Text] [Related]
54. A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab's epitope with versatile biochemical, biological, and medical applications. Nikkhoi SK; Heydarzadeh H; Vandavasi VG; Yang G; Louro P; Polunas M; Owji H; Hatefi A Immunol Res; 2024 Feb; 72(1):103-118. PubMed ID: 37632647 [TBL] [Abstract][Full Text] [Related]
55. Preparation of a naïve library of camelid single domain antibodies. Olichon A; de Marco A Methods Mol Biol; 2012; 911():65-78. PubMed ID: 22886246 [TBL] [Abstract][Full Text] [Related]
56. Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein. Liu JL; Shriver-Lake LC; Anderson GP; Zabetakis D; Goldman ER Microb Cell Fact; 2017 Dec; 16(1):223. PubMed ID: 29233140 [TBL] [Abstract][Full Text] [Related]
57. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells. Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371 [TBL] [Abstract][Full Text] [Related]
58. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display. Salema V; Mañas C; Cerdán L; Piñero-Lambea C; Marín E; Roovers RC; Van Bergen En Henegouwen PM; Fernández LÁ MAbs; 2016 Oct; 8(7):1286-1301. PubMed ID: 27472381 [TBL] [Abstract][Full Text] [Related]
59. Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine. Pille J; van Lith SA; van Hest JC; Leenders WP Biomacromolecules; 2017 Apr; 18(4):1302-1310. PubMed ID: 28269985 [TBL] [Abstract][Full Text] [Related]
60. Selection of similar single domain antibodies from two immune VHH libraries obtained from two alpacas by using different selection methods. Li T; Vandesquille M; Bay S; Dhenain M; Delatour B; Lafaye P Immunol Lett; 2017 Aug; 188():89-95. PubMed ID: 28690185 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]